Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Adil I. Daud"'
Autor:
Zoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, Chaorong Wu, Clinton Wu, Laura Huppert, Lauren S. Levine, Paula Sison, Katy K. Tsai, Melissa Chow, Jee Hye Kang, Jimmy Hwang, James C. Lee, Ariel Oglesby, Jessica Venegas, Ben J. Brintz, Aik Choon Tan, Mark S. Anderson, Michael D. Rosenblum, Arabella Young, Adil I. Daud
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-10 (2024)
Abstract Objective Many patients with melanoma treated with immune checkpoint inhibitors (ICIs) do not derive response. Preclinical and retrospective studies identified that inhibition of the cyclooxygenase (COX) pathway may improve response to ICI t
Externí odkaz:
https://doaj.org/article/c105ad53a05b4e0fa71f9d23c963083c
Autor:
Paul Wong, Andrew D. Wisneski, Katy K. Tsai, Tammy T. Chang, Kenzo Hirose, Eric K. Nakakura, Adil I. Daud, Ajay V. Maker, Carlos U. Corvera
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-6 (2024)
Abstract Background Metastatic melanoma to the small bowel is an aggressive disease often accompanied by obstruction, abdominal pain, and gastrointestinal bleeding. With advancements in melanoma treatment, the role for metastasectomy continues to evo
Externí odkaz:
https://doaj.org/article/c3b703395f04418f839076eadec3f3b4
Autor:
Laura A. Huppert, Adil I. Daud
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 3 (2022)
Skin cancers are among the most physically accessible malignancies, so local delivery of a medication into the tumor, so-called intratumoral therapy, is an appealing route of drug administration. Intratumoral therapies have the potential to increase
Externí odkaz:
https://doaj.org/article/5a149a5fc2904dbfa480f8b2cce87c9b
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-5 (2018)
Abstract Background Patients with metastatic Merkel cell carcinoma (mMCC) who experience disease progression on immunotherapy have limited additional standard options. Given evidence of synergism between radiation therapy (RT) and immunotherapy, two
Externí odkaz:
https://doaj.org/article/476bdde295a140f494854efe0e46e5a6
Autor:
Katy Tsai, Miguel H. Pampaloni, Charity Hope, Alain P. Algazi, Britt-Marie Ljung, Laura Pincus, Adil I. Daud
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Background Antibodies against programmed death 1 (PD-1) receptor and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) have transformed the systemic treatment of melanoma and many other cancers. Understanding the spectrum of benign findings and at
Externí odkaz:
https://doaj.org/article/5fc8dd8e55534aa4a2332afa1f934eb0
Autor:
Drew W. Rasco, Theresa Medina, Pippa Corrie, Anna C. Pavlick, Mark R. Middleton, Paul Lorigan, Chris Hebert, Ruth Plummer, James Larkin, Sanjiv S. Agarwala, Adil I. Daud, Jiaheng Qiu, Viviana Bozon, Michelle Kneissl, Elly Barry, Anthony J. Olszanski
Publikováno v:
Cancer chemotherapy and pharmacology, vol 92, iss 1
Purpose Genomic alterations of BRAF and NRAS are oncogenic drivers in malignant melanoma and other solid tumors. Tovorafenib is an investigational, oral, selective, CNS-penetrant, small molecule, type II pan‑RAF inhibitor. This first-in-human phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be879ecf897194f5e93f0a32cbcfa4d
https://www.repository.cam.ac.uk/handle/1810/350906
https://www.repository.cam.ac.uk/handle/1810/350906
Autor:
Lawrence Fong, Adil I. Daud, Mai H. Le, Robert H. Pierce, Alan Paciorek, Li Zhang, Christopher G. Twitty, Lawrence Chen, Kathryn T. Takamura, Katy K. Tsai, Alain P. Algazi, Samantha K. Greaney
Whereas systemic IL12 is associated with potentially life-threatening toxicity, intratumoral delivery of IL12 through tavokinogene telseplasmid electroporation (tavo) is safe and can induce tumor regression at distant sites. The mechanism by which th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ba2b2721404c2e21aea696350dbd37
https://doi.org/10.1158/2326-6066.c.6550222.v1
https://doi.org/10.1158/2326-6066.c.6550222.v1
Autor:
Lawrence Fong, Adil I. Daud, Mai H. Le, Robert H. Pierce, Alan Paciorek, Li Zhang, Christopher G. Twitty, Lawrence Chen, Kathryn T. Takamura, Katy K. Tsai, Alain P. Algazi, Samantha K. Greaney
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd29f92e0542fe150bc20a0a767f4d2
https://doi.org/10.1158/2326-6066.22543339.v1
https://doi.org/10.1158/2326-6066.22543339.v1
Autor:
Lawrence Fong, Adil I. Daud, Mai H. Le, Robert H. Pierce, Alan Paciorek, Li Zhang, Christopher G. Twitty, Lawrence Chen, Kathryn T. Takamura, Katy K. Tsai, Alain P. Algazi, Samantha K. Greaney
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a38f95a7d47fb4f42ac46e7f9e5046
https://doi.org/10.1158/2326-6066.22543342.v1
https://doi.org/10.1158/2326-6066.22543342.v1
Autor:
Christopher G. Twitty, David A. Canton, Adil I. Daud, Alain P. Algazi, William L. Redmond, Annah S. Rolig, Lauren Svenson, Reneta Hermiz, Jon Salazar, Ravindra Gujar, Anandaroop Mukhopadhyay, Jun Zhang, Erica Browning, Jack Y. Lee, Bianca Nguyen, Mia Han
Supplementary Data from Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3eed745c165b1ea13499b90e81ce99
https://doi.org/10.1158/1541-7786.22527632
https://doi.org/10.1158/1541-7786.22527632